EUROPE: +44 (0)1223 727 123 | USA: 800-686-4407

Home
About Us
- About Us
  About Us
  Mission Statement
  Testimonials
  Benefits of Syngene
  OEM opportunities
  Meet the team
  Careers
- About Us
  
  We are a division of the Synoptics Group, founded in 1985 by imaging experts from the University of Cambridge. Synoptics is owned by Scientific Digital Imaging plc. At Syngene we live and breathe image analysis because products specifically for gel documentation and fluorescence/chemiluminescence imaging are all we’ve ever focused on. That’s why we have developed systems specifically designed to enhance your imaging experience.
Products
- Product Categories
  Gel documentation systems
  Chemiluminescence systems
  Chemiluminescence & Fluorescence systems
  Electrophoresis systems
- Products
  DigiGenius
  InGenius3
  NuGenius/NuGenius+
  G:BOX F3
  GeneGnome XRQ
  G:BOX Chemi XRQ
  G:BOX mini 6/9
  G:BOX Chemi XX6/XX9
- Syngene Products
  We produce a world leading range of gel documentation (gel doc) systems for rapid, accurate imaging and analysis of 1D DNA/RNA gels, 1D and 2D protein gels, chemiluminescent Westerns, multiplexed fluorescent dye blots, multiplexed gels and infra-red blots.
  
  PRODUCT BROCHURES
Applications
- Applications
  Fluorescence Applications
  Chemiluminescence & Fluorescence Applications
  Chemiluminescence Applications
  Application Notes
- Applications
  Syngene supplies gel documentation imaging systems for a wide range of applications.
  
  Read more in our Application Notes library:
  
  APPLICATION NOTES
Software
- Software
  GeneSys
  GeneTools
  Dymension
  GeneDirectory
  Software Downloads
- Software
  Syngene offers a range of software for our gel documentation imaging systems with a unique software guarantee providing free updates of GeneSys and GeneTools packages for the life of the system.
Where to buy
- Where to buy
  Europe
  North America
  South America
  Asia & Australasia
  Africa & Middle East
- Where to buy
  Syngene have distributors around the world.
Support
- Support
  Support
  FAQs
  Online Training
  Warranty registration
  Glossary
- Documents
  Technical Papers
  Quick Guides
  Software Downloads
- Support
  To get support on Syngene systems you can fill in an on-line form, send us an email or visit our support helpdesk:
  
  FORM
  
  EMAIL
  
  HELPDESK
News
- News
- Shows
Contact Us
Search for:

Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells

Home

Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells

2019-07-24T15:15:09+01:00July 24th, 2019|

This article cites the use of GeneGnome XRQ chemiluminescence imaging system and GeneTools analysis software.

Download as PDF file
Link to original article

Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells

Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells

Share This Story, Choose Your Platform!